Despite the fact that the exact role of the anti-U1 RNP antibody in CTD-PAH pathogenesis remains unclear, it is predicted that this antibody may contribute to the PAH development by participating in vasculopathy. The gene discussed is RNPC3; the disease is vascular disorder.